http://www.aabp.co.jp/jp/201310 40020132020 ---- Amgen Astellas BioPharma K.K.http://www.aabp.co.jp/jp/ is a Japanese company that began operations on October 1, 2013, to provide breakthrough-science-based medicines to help address unmet medical needs of patients in Japan. The company is a joint venture between Amgen, one of the worlds leading independent biotechnology companies, and Astellas Pharma Inc., a leading Tokyo-based R&D oriented global pharmaceutical company. AABP has grown into an organization with over 400 employees and comprehensive functions to be fully operational as a marketing authorization holder in Japan. The joint venture will become a wholly-owned Amgen affiliate as soon as 2020.
http://www.aabp.co.jp/jp/201310 40020132020 ---- Amgen Astellas BioPharma K.K.http://www.aabp.co.jp/jp/ is a Japanese company that began operations on October 1, 2013, to provide breakthrough-science-based medicines to help address unmet medical needs of patients in Japan. The company is a joint venture between Amgen, one of the worlds leading independent biotechnology companies, and Astellas Pharma Inc., a leading Tokyo-based R&D oriented global pharmaceutical company. AABP has grown into an organization with over 400 employees and comprehensive functions to be fully operational as a marketing authorization holder in Japan. The joint venture will become a wholly-owned Amgen affiliate as soon as 2020.
Company Information
- Industry
- Pharmaceuticals
- Company Type
- Privately Held
- Founded
- unknown
- Employee Range
- 51-200
- Revenue Range
- Not available
Location
- Address
- 1-7-12 Marunouchi Tokyo Chiyoda-ku
- City
- Tokyo
- Region
- Tokyo
- Postal Code
- 100-0005
- Country
- Japan